In addition to the above, GLP-1 agonists help repair damage to our metabolism and repair pathways that are broken and leading to stubborn weight or health issues
Leite, Alex Carvalho, and Ademir Carvalho Leite Jr
This decrease in caloric consumption, combined with potential gastrointestinal side effects such as nausea, vomiting, and diarrhoea, may increase the risk of micronutrient deficiencies in certain individuals
Tumors require blood supply to grow beyond a certain size, and they hijack angiogenic pathways to build their own vascular networks
Carlos, E
The Phase 3 ENLIGHTEN-Fibrosis trial in non-cirrhotic (F2-F3) MASH and Phase 3 ENLIGHTEN-Cirrhos is trial in compensated cirrhotic (F4) MASH continue to enroll patients, with topline data from the histology cohorts of these trials expected in the first half of 2027 and in 2028, respectively